Methemoglobinemia Risk in Infants Due to Benzocaine Exposure

Risk Factors and Pathophysiology

Infants are at high risk for developing methemoglobinemia from benzocaine exposure because they have lower levels of the enzyme cytochrome b5 reductase, approximately 50-60% of adult values, making them more susceptible to the toxic effects of benzocaine 1
Fetal hemoglobin is more easily oxidized to methemoglobin than adult hemoglobin, further increasing vulnerability in young infants 1
Methemoglobin levels >70% are potentially lethal, and even therapeutic application of benzocaine teething gels has resulted in methemoglobin levels of 20-69.9% in documented cases 1

Breastfeeding during discomfort has been shown to effectively reduce pain in infants, as recommended by the American Academy of Pediatrics 2
Oral sucrose (0.1-1 mL of 24% solution or 0.2-0.5 mL/kg) given 2 minutes before anticipated discomfort is a safe and effective alternative, according to the American Academy of Pediatrics 3
Skin-to-skin contact (kangaroo care) provides comfort and pain relief, as suggested by the American Academy of Pediatrics 4

Acetaminophen (paracetamol) at appropriate weight-based dosing is safe and effective for teething discomfort, as recommended by the American Academy of Pediatrics 3
Ibuprofen (for infants ≥6 months) at appropriate weight-based dosing is a safe and effective option, according to the American Academy of Pediatrics 5

Slate-gray or dusky blue cyanosis that does not improve with oxygen administration is a sign of methemoglobinemia, and immediate treatment with methylene blue is necessary, as recommended by the American Society of Hematology 1
Treatment requires immediate methylene blue 1-2 mg/kg IV over 3-5 minutes, which should reduce methemoglobin levels within 30-60 minutes, according to the American Society of Hematology 1